keyword
https://read.qxmd.com/read/38612483/the-pd-1-pd-l1-axis-in-the-biology-of-masld
#1
REVIEW
Rosaria Maria Pipitone, Giulia Lupo, Rossella Zito, Ayesha Javed, Salvatore Petta, Grazia Pennisi, Stefania Grimaudo
Metabolic Dysfunction-Associated Steatotic Liver (MASL), previously named nonalcoholic fatty liver (NAFL), is a multifactorial disease in which metabolic, genetic, and environmental risk factors play a predominant role. Obesity and type 2 diabetes act as triggers of the inflammatory response, which contributes to the progression of MASL to Metabolic Dysfunction-Associated Steatohepatitis and the development of hepatocellular carcinoma. In the liver, several parenchymal, nonparenchymal, and immune cells maintain immunological homeostasis, and different regulatory pathways balance the activation of the innate and adaptative immune system...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38604551/type-1-diabetes-brazilian-patients-exhibit-reduced-frequency-of-recent-thymic-emigrants-in-regulatory-cd4-cd25-foxp3-t-cells
#2
JOURNAL ARTICLE
Jeane de Souza Nogueira, Thamires Rodrigues Gomes, Danielle Angst Secco, Inez Silva de Almeida, Alessandra Saldanha Matheus Fernandes da Costa, Roberta Arnoldi Cobas, Gilson Costados Santos, Marília Brito Gomes, Luís Cristóvão Pôrto
To control immune responses, regulatory CD4+ CD25+ Foxp3+ T cells (Treg) maintain their wide and diverse repertoire through continuous arrival of recent thymic emigrants (RTE). However, during puberty, the activity of RTE starts to decline as a natural process of thymic involution, introducing consequences, not completely described, to the repertoire. Type 1 diabetes (T1D) patients show quantitative and qualitative impairments on the Treg cells. Our aim was to evaluate peripheral Treg and RTE cell frequencies, in T1D patients from two distinct age groups (young and adults) and verify if HLA phenotypes are concomitant associated...
April 9, 2024: Immunology Letters
https://read.qxmd.com/read/38599099/modulatory-effect-of-interleukin-2-loaded-chitosan-nano-sphere-on-regulatory-t-cell-activity-in-streptozotocin-induced-diabetic-mice
#3
JOURNAL ARTICLE
Salma Aboelnazar, Hossam Ghoneim, Thanaa Shalaby, Sally Sorour, Eman M Osman
OBJECTIVE: The current study aimed to assess the modulating effect of IL-2 encapsulated chitosan-nanoparticles (CSNPs) on the function of Treg cells through induction of type 1 diabetes (T1D). Treg cell function was monitored by the forkhead box P3 (FoxP3) and transforming growth factor beta (TGFβ) levels, correlating them with blood glucose and serum insulin levels. MATERIALS AND METHODS: In this case-control study, a low dose of IL-2 (free and chitosan-loaded) was injected into a diabetic mice group...
April 9, 2024: International Immunopharmacology
https://read.qxmd.com/read/38582367/accelerated-closure-of-diabetic-wounds-by-efficient-recruitment-of-fibroblasts-upon-inhibiting-a-14-3-3-rock-regulatory-axis
#4
JOURNAL ARTICLE
M Zahied Johan, Natasha T Pyne, Natasha Kolesnikoff, Valentina Poltavets, Zahra Esmaeili, Joanna M Woodcock, Angel F Lopez, Allison J Cowin, Stuart M Pitson, Michael S Samuel
Chronic non-healing wounds negatively impact on quality of life and are a significant financial drain on health systems. The risk of infection that exacerbates co-morbidities in patients necessitates regular application of wound care. Understanding mechanisms underlying impaired wound healing are therefore a key priority to inform effective new generation treatments. Here, we demonstrate that 14-3-3-mediated suppression of signaling through ROCK is a critical mechanism that inhibits the healing of diabetic wounds...
April 4, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38581053/regulatory-t-cells-limit-age-associated-retinal-inflammation-and-neurodegeneration
#5
JOURNAL ARTICLE
María Llorián-Salvador, Alerie G de Fuente, Christopher E McMurran, Amy Dashwood, James Dooley, Adrian Liston, Rosana Penalva, Yvonne Dombrowski, Alan W Stitt, Denise C Fitzgerald
BACKGROUND: Ageing is the principal risk factor for retinal degenerative diseases, which are the commonest cause of blindness in the developed countries. These conditions include age-related macular degeneration or diabetic retinopathy. Regulatory T cells play a vital role in immunoregulation of the nervous system by limiting inflammation and tissue damage in health and disease. Because the retina was long-considered an immunoprivileged site, the precise contribution of regulatory T cells in retinal homeostasis and in age-related retinal diseases remains unknown...
April 5, 2024: Molecular Neurodegeneration
https://read.qxmd.com/read/38574576/characteristics-and-functions-of-memory-regulatory-t-cells-in-normal-pregnancy-cycle-and-pregnancy-complications
#6
JOURNAL ARTICLE
Zeyang Chen, Xiaojiao Zhou, Hongmei Qu, Xiaolu Zhang, Joanne Kwak-Kim, Wenjuan Wang
Regulatory T cells (Tregs) are activated and expanded after exposure to fetal-specific (paternal) antigens. A proportion of Tregs differentiate into memory Tregs (mTregs), exhibiting immune memory function and exerting more potent immunosuppression than naive Tregs (nTregs). However, it is unclear how mTregs are regulated during normal and pathological pregnancies (e.g., gestational diabetes mellitus (GDM) and preeclampsia (PE)). In this study, PD-1, HLA-G, and HLA-DR expressions on memory CD4+ T cells, naive CD4+ T cells, Tregs, mTregs, and nTregs in healthy non-pregnant women (n=20), healthy first (n=20), second (n=20), and third-trimester women (n=20), postpartum women (n=20), GDM (n=20), and PE patients (n=20) were analyzed...
March 19, 2024: Journal of Reproductive Immunology
https://read.qxmd.com/read/38557820/supplementation-of-high-strength-oral-probiotics-improves-immune-regulation-and-preserves-beta-cells-among-children-with-new-onset-type-1-diabetes-mellitus-a-randomised-double-blind-placebo-control-trial
#7
JOURNAL ARTICLE
M N Lokesh, Rakesh Kumar, Neenu Jacob, Naresh Sachdeva, Amit Rawat, Jaivinder Yadav, Devi Dayal
OBJECTIVES: To investigate the mechanism of glycemic control in children with type 1 diabetes (T1D) following high-strength probiotics supplementation by assessing immune-regulatory markers. METHODS: In this single-centre randomised double-blinded placebo-controlled study, children with new-onset T1D on regular insulin therapy were randomised into probiotic or placebo groups with 30 children each. The probiotics group received oral powder of Vivomixx® , and the placebo group received corn starch for six months...
April 1, 2024: Indian Journal of Pediatrics
https://read.qxmd.com/read/38554443/pd-1-receptor-t-cells-are-associated-with-the-efficacy-of-the-combined-treatment-with-regulatory-t-cells-and-rituximab-in-type-1-diabetes-children-via-regulatory-t-cells-suppressive-activity-amelioration
#8
JOURNAL ARTICLE
Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz-Grześ, Mateusz Gliwiński, Matylda Hennig, Magdalena Żalińska, Anna Wołoszyn-Durkiewicz, Anna Jaźwińska-Curyłło, Halla Kamińska, Radosław Owczuk, Wojciech Młynarski, Przemysława Jarosz-Chobot, Artur Bossowski, Agnieszka Szadkowska, Wojciech Fendler, Iwona Beń-Skowronek, Agata Chobot, Małgorzata Myśliwiec, Janusz Siebert, Natalia Marek-Trzonkowska, Piotr Trzonkowski
An imbalance between exaggerated autoaggressive T cell responses, primarily CD8 + T cells, and impaired tolerogenic mechanisms underlie the development of type 1 diabetes mellitus. Disease-modifying strategies, particularly immunotherapy focusing on FoxP3 + T regulatory cells (Treg), and B cells facilitating antigen presentation for T cells, show promise. Selective depletion of B cells may be achieved with an anti-CD20 monoclonal antibody (mAb). In a 2-year-long flow cytometry follow-up, involving 32 peripheral blood T and B cell markers across three trial arms (Treg + rituximab N = 12, Treg + placebo N = 13, control N = 11), we observed significant changes...
March 29, 2024: International Immunopharmacology
https://read.qxmd.com/read/38548394/-effect-and-mechanism-of-human-adipose-derived-stem-cell-exosomes-on-diabetic-peripheral-neuropathy
#9
JOURNAL ARTICLE
T Cao, T Hao, D Xiao, W F Zhang, P Ji, Y H Jia, J Wang, X J Wang, H Guan, K Tao
Objective: To investigate the changes of artemin protein expression in diabetic peripheral neuropathy (DPN) and to explore the regulatory effect of human adipose-derived stem cell (ADSC) exosomes on the change of artemin protein expression. Methods: This research was a prospective observational clinical research combined with experimental research. Thirteen DPN patients (9 males and 4 females, aged 32 to 68 years) who were admitted to the First Affiliated Hospital of Air Force Medical University (hereinafter referred to as our hospital) from May 2022 to October 2023 and met the inclusion criteria were selected as DPN group, and 5 non-diabetes patients (4 males and 1 female, aged 29 to 61 years) who were admitted to our hospital in the same period of time and met the inclusion criteria were selected as control group...
March 20, 2024: Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
https://read.qxmd.com/read/38528189/identification-of-hdac9-and-arrdc4-as-potential-biomarkers-and-targets-for-treatment-of-type-2-diabetes
#10
JOURNAL ARTICLE
Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
We aimed to identify the key potential insulin resistance (IR)-related genes and investigate their correlation with immune cell infiltration in type 2 diabetes (T2D). The GSE78721 dataset (68 diabetic patients and 62 controls) was downloaded from the Gene Expression Omnibus database and utilized for single-sample gene set enrichment analysis. IR-related genes were obtained from the Comparative Toxicology Genetics Database, and the final IR-differentially expressed genes (DEGs) were screened by intersecting with the DEGs obtained from the GSE78721 datasets...
March 25, 2024: Scientific Reports
https://read.qxmd.com/read/38524122/corrigendum-regulatory-t-cells-targeting-a-pathogenic-mhc-class-ii-insulin-peptide-epitope-postpone-spontaneous-autoimmune-diabetes
#11
Nyerhovwo Obarorakpor, Deep Patel, Reni Boyarov, Nansalmaa Amarsaikhan, Joseph Ray Cepeda, Doreen Eastes, Sylvia Robertson, Travis Johnson, Kai Yang, Qizhi Tang, Li Zhang
[This corrects the article DOI: 10.3389/fimmu.2023.1207108.].
2024: Frontiers in Immunology
https://read.qxmd.com/read/38515175/multiply-restimulated-human-cord-blood-derived-tregs-maintain-stabilized-phenotype-and-suppressive-function-and-predict-their-therapeutic-effects-on-autoimmune-diabetes
#12
JOURNAL ARTICLE
Yuanjie Bi, Ran Kong, Yani Peng, Donghua Cai, Yu Zhang, Fan Yang, Xia Li, Wen Deng, Fang Liu, Binbin He, Chuqing Cao, Chao Deng, Xiaohan Tang, Li Fan, Haibo Yu, Zhiguang Zhou
BACKGROUND: Regulatory T cells (Tregs) are involved in the maintenance of immune homeostasis and immune regulation. Clinical trials on the adoptive transfer of Tregs have been ongoing for > 10 years. However, many unresolved issues remain in the production of readymade Treg products and selection of patients. Hence, this study aimed to develop a method to expand off-the-shelf Tregs derived from umbilical cord blood (UCB-Tregs) in vitro without changing their phenotype and inhibitory function...
March 21, 2024: Diabetology & Metabolic Syndrome
https://read.qxmd.com/read/38455510/adipose-tissue-lymphocytes-and-obesity
#13
JOURNAL ARTICLE
Feng Gao, Benjamin Litchfield, Huaizhu Wu
Obesity is associated with chronic inflammation in adipose tissue (AT), mainly evidenced by infiltration and phenotypic changes of various types of immune cells. Macrophages are the major innate immune cells and represent the predominant immune cell population within AT. Lymphocytes, including T cells and B cells, are adaptive immune cells and constitute another important immune cell population in AT. In obesity, CD8+ effector memory T cells, CD4+ Th1 cells, and B2 cells are increased in AT and promote AT inflammation, while regulatory T cells and Th2 cells, which usually function as immune regulatory or type 2 inflammatory cells, are reduced in AT...
January 2024: The journal of cardiovascular aging
https://read.qxmd.com/read/38424350/assessing-the-effectiveness-of-interleukin-2-therapy-in-experimental-type-1-diabetes
#14
JOURNAL ARTICLE
Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
AIM: Much focus of immunotherapy for type 1 diabetes (T1D) has been devoted on selectively boosting regulatory T (Treg) cells using low dose IL-2 due to their constitutive expression of IL-2Rα, CD25. However, several clinical trials using a low dose of IL-2 only showed a limited improvement of metabolic control. It can therefore be hypothesized that further decreasing IL-2 dosage may increase the selective responsiveness of Treg cells. METHODS: We induced experimental T1D using multiple low dose streptozotocin (STZ) injections and treated the mice with an ultra-low dose IL-2 (uIL-2, approximately 7-fold lower than low dose)...
February 29, 2024: Endocrine
https://read.qxmd.com/read/38421704/enhancing-human-treg-cell-induction-through-engineered-dendritic-cells-and-zinc-supplementation
#15
JOURNAL ARTICLE
Nisar Ali Shaikh, Xiao-Bing Zhang, Maisa I Abdalla, David J Baylink, Xiaolei Tang
Regulatory T (Treg) cells hold promise for the ultimate cure of immune-mediated diseases. However, how to effectively restore Treg function in patients remains unknown. Previous reports suggest that activated dendritic cells (DCs) de novo synthesize locally high concentrations of 1,25-dihydroxy vitamin D, i.e., the active vitamin D or 1,25(OH)2D by upregulating the expression of 25-hydroxy vitamin D 1α-hydroxylase. Although 1,25(OH)2D has been shown to induce Treg cells, DC-derived 1,25(OH)2D only serves as a checkpoint to ensure well-balanced immune responses...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38418860/phenotypic-characterisation-of-regulatory-t-cells-in-patients-with-gestational-diabetes-mellitus
#16
JOURNAL ARTICLE
Ya-Nan Zhang, Qin Wu, Yi-Hui Deng
Gestational diabetes mellitus (GDM) is a common complication that occurs during pregnancy. Emerging evidence suggests that immune abnormalities play a pivotal role in the development of GDM. Specifically, regulatory T cells (Tregs) are considered a critical factor in controlling maternal-fetal immune tolerance. However, the specific characteristics and alterations of Tregs during the pathogenesis of GDM remain poorly elucidated. Therefore, this study aimed to investigate the changes in Tregs among pregnant women diagnosed with GDM compared to healthy pregnant women...
February 28, 2024: Scientific Reports
https://read.qxmd.com/read/38404576/the-type-1-diabetes-susceptibility-locus-idd5-favours-robust-neonatal-development-of-highly-autoreactive-regulatory-t-cells-in-the-nod-mouse
#17
JOURNAL ARTICLE
Jérémy C Santamaria, Sylvia Vuillier, Ariel O Galindo-Albarrán, Sarah Castan, Claire Detraves, Olivier P Joffre, Paola Romagnoli, Joost P M van Meerwijk
Regulatory T lymphocytes expressing the transcription factor Foxp3 (Tregs) play an important role in the prevention of autoimmune diseases and other immunopathologies. Aberrations in Treg-mediated immunosuppression are therefore thought to be involved in the development of autoimmune pathologies, but few have been documented. Recent reports indicated a central role for Tregs developing during the neonatal period in the prevention of autoimmune pathology. We therefore investigated the development of Tregs in neonatal NOD mice, an important animal model for autoimmune type 1 diabetes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38387059/cell-surface-znt8-antibody-prevents-and-reverses-autoimmune-diabetes-in-mice
#18
JOURNAL ARTICLE
Devi Kasinathan, Zheng Guo, Dylan C Sarver, G William Wong, Shumei Yun, Aaron W Michels, Liping Yu, Chandan Sona, Matthew N Poy, Maria L Golson, Dax Fu
Type 1 diabetes (T1D) is an autoimmune disease where pathogenic lymphocytes target autoantigens expressed in the pancreatic islets, leading to the destruction of insulin-producing β-cells. Zinc transporter 8 (ZnT8) is a major autoantigen abundantly present on the β-cell surface. This unique molecular target offers the potential to shield β-cells against autoimmune attacks in T1D. Our previous work showed that a monoclonal antibody (mAb43) against cell-surface ZnT8 can home in on the pancreatic islets and prevent autoantibodies from recognizing β-cells...
February 22, 2024: Diabetes
https://read.qxmd.com/read/38380914/evaluating-the-effects-of-chronic-oral-exposure-to-the-food-additive-silicon-dioxide-on-oral-tolerance-induction-and-food-sensitivities-in-mice
#19
JOURNAL ARTICLE
Bruno Lamas, Natalia Martins Breyner, Yann Malaisé, Mark Wulczynski, Heather J Galipeau, Eric Gaultier, Christel Cartier, Elena F Verdu, Eric Houdeau
BACKGROUND: The increasing prevalence of food sensitivities has been attributed to changes in gut microenvironment; however, ubiquitous environmental triggers such as inorganic nanoparticles (NPs) used as food additives have not been thoroughly investigated. OBJECTIVES: We explored the impact of the NP-structured food-grade silicon dioxide (<mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>f</mml:mi><mml:mi>g</mml:mi><mml:mtext>-</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>SiO</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>) on intestinal immune response involved in oral tolerance (OT) induction and evaluated the consequences of oral chronic exposure to this food-additive using a mouse model of OT to ovalbumin (OVA) and on gluten immunopathology in mice expressing the celiac disease risk gene, HLA-DQ8...
February 2024: Environmental Health Perspectives
https://read.qxmd.com/read/38351729/candidate-biomarkers-for-targeting-in-type-1-diabetes-a-bioinformatic-analysis-of-pancreatic-cell-surface-antigens
#20
JOURNAL ARTICLE
Hamed Dabiri, Mahdi Habibi-Anbouhi, Vahab Ziaei, Zahra Moghadasi, Majid Sadeghizadeh, Ensiyeh Hajizadeh-Saffar
OBJECTIVE: Type 1 diabetes (T1Ds) is an autoimmune disease in which the immune system invades and destroys insulin-producing cells. Nevertheless, at the time of diagnosis, about 30-40% of pancreatic beta cells are healthy and capable of producing insulin. Bi-specific antibodies, chimeric antigen receptor regulatory T cells (CAR-Treg cells), and labeled antibodies could be a new emerging option for the treatment or diagnosis of type I diabetic patients. The aim of the study is to choose appropriate cell surface antigens in the pancreas tissue for generating an antibody for type I diabetic patients...
January 31, 2024: Cell Journal
keyword
keyword
99476
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.